Bafna Pharmaceuticals Ltd

532989

Summary

Fair Value Assessment
Fairly Valued
Fair ValueQ78.42UncertaintyHigh
Close Price75.00Jun 11, 2025
Market Closed
74.41
Price Down by 0.59 | 0.79 %
Previous Close
75.00
Day Range
73.02 – 75.29
Year Range
67.80 – 94.80
Bid / Ask
Market Cap
1.8 Bil
Volume / Average
580.0 / 1.1 k
Beta (5-Year)
Shares Outstanding
23.66 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Bafna Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in the manufacturing and marketing of drugs and medicines. The company sells its products in India and international regions. The company has only one Segment of Business namely Pharmaceuticals.
Contact
Thambu Chetty Street New No. 68, Old No.299, Bafna Towers, Chennai, TN 600001
T +91 4425267517
www.bafnapharma.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
363

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Mil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
1,458.58 1,458.58 1,524.66 1,153.50 851.40 712.18
Revenue Growth %
-4.33% -4.33% 32.18% 35.48% 19.55% 67.68%
Gross Profit
427.97 427.97 455.59 387.56 338.55 257.62
Gross Profit Margin %
29.34% 29.34% 29.88% 33.60% 39.76% 36.17%
Operating Income
62.88 62.88 74.00 120.68 64.35 61.38
Operating Margin %
4.31% 4.31% 4.85% 10.46% 7.56% 8.62%
EBIT
68.84 68.84 91.60 133.69 77.87 58.76
EBIT Margin %
4.72% 4.72% 6.01% 11.59% 9.15% 8.25%
EBITDA
117.73 117.73 141.56 187.04 132.81 103.54
EBITDA Margin %
8.07% 8.07% 9.28% 16.21% 15.60% 14.54%
Net Income
41.53 41.53 73.48 113.38 51.51 58.27
Net Profit Margin %
2.85% 2.85% 4.82% 9.83% 8.58% 8.18%
Basic EPS
1.76 1.76 3.11 4.79 2.17 2.46
Diluted EPS
1.76 1.76 3.11 4.79 2.17 2.46
Normalized EPS
Total Dividends per Share
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Mil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
1,530.79 1,530.79 1,476.82 1,295.83 902.44 864.66
Total Liabilities
682.73 682.73 668.43 561.29 273.64 296.95
Total Debt
281.99 281.99 243.89 229.24 90.43 157.86
Total Equity
848.07 848.07 808.39 734.55 628.80 567.71
Cash And Cash Equivalents
34.33 34.33 13.96 66.63 0.19 7.48
Working Capital
343.27 343.27 403.87 408.35 350.09 253.60
Shares Outstanding (Mil)
23.66 23.66
Book Value Per Share
35.85 35.85 34.17 31.05 26.58 24.00
Total Debt To Equity
0.33 0.33 0.30 0.31 0.14 0.28
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Mil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
221.36 94.85 49.53 80.32 -136.09 -343.09
Cash From Investing Activities
-211.63 -150.54 -74.93 -54.39 -53.45 327.75
Cash From Financing Activities
10.64 -8.45 101.77 -42.24 122.80 73.01
Capital Expenditures
218.60 158.48 82.19 75.41 60.95 14.29
Free Cash Flow
-100.18 -33.95 96.20 9.77 34.61 -228.60
Change in Cash
20.37 -64.14 76.37 -16.31 -66.75 57.68

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top